Ensuring the Future of Innovation
Researchers Find Ancestry Impacts Effectiveness of Prostate Cancer Drugs
Dana-Farber Research Opens the Door to Finding More Effective Treatments for Ewing Sarcoma
Dana-Farber Research Supports FDA Approval of Sevabertinib for HER2-Mutant Lung Cancer
Dana-Farber Cancer Institute Faculty Among World's Most Highly Cited Researchers
Dana-Farber Research Points to Potential Gene Therapy Improvements
Three Ways Research Could Improve Pancreatic Cancer Treatment
Forcing Cancer to Grow Up: Dana-Farber Scientists Reprogram Tumors to Behave Normally
FDA Approves Menin Inhibitor for Patients With Acute Leukemia With NPM1 Mutation, Backed by Dana-Farber Science
Pan-Mass Challenge Raises Record $78 Million for Dana-Farber Cancer Institute
CD123 Targeted Therapies
Acute Myeloid Leukemia Triplet Therapies: Easy as 1, 2, 3
Menin Inhibitors: A New Class of Anti-Leukemic Agents
A Brighter Future for B-ALL in Adults
Bringing Specialists Together: Tandem Leukemia and Stem Cell Transplant Consults
Showing 46 - 60 of 1020 results
Previous| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ...68 |Next
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
